CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer) — SEC DEFM14A Filing
Apotex→Cumberland Pharmaceuticals
May 26, 2026
Track acquisitions, mergers, and investments in the healthcare sector.
Tentt has tracked 666 healthcare M&A deals, with 225 transactions recorded in the last 30 days. The most active sub-sectors include Healthcare Services Other (163), Pharmacy (135), Medical Devices (106), Healthcare It (40).
California leads with 55 deals, followed by New York and Florida. Strategic accounts for 68% of buyer activity in this sector, with Private Equity (145), Public Company (27) also active.
The most recent transaction tracked is "Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18."
Apotex→Cumberland Pharmaceuticals
May 26, 2026
Olympus→BioProtect
May 26, 2026
Ligand Pharmaceuticals→XOMA Royalty Holdings
May 26, 2026
Apotex→Cumberland Pharmaceuticals
May 26, 2026
PharmaCorp Rx→PharmaChoice Canada bannered pharmacy
May 25, 2026
Gujarat Themis Biosyn→MicroBiopharm
May 25, 2026
Gujarat Themis Biosyn→MicroBiopharm
May 25, 2026
Gujarat Themis Biosyn→MicroBiopharm Japan
May 25, 2026
Anupam Rasayan→Bliss GVS Pharma
May 24, 2026
Motivity→Calmanac
May 22, 2026
Innovaccer→Caduceus Health
May 22, 2026
Avista Healthcare Partners→sanotact Group
May 22, 2026
NervGen Pharma
May 22, 2026
Ascension→AmSurg
May 21, 2026
May 21, 2026
RA Capital Management
May 21, 2026
InnocsAI
May 21, 2026
Lauxera Capital Partners
May 21, 2026
InSphero→PhenoVista Biosciences
May 21, 2026
IKS Health→TruBridge
May 21, 2026